SEC Form 4 · accession 0000950138-16-001132
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew K Harbaugh
Officer — Sr. VP & CFO
Period of report
May 10, 2016
Accepted (ET)
May 11, 2016 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | May 10, 2016 | P | 500 | $59.368 | A | 56,036 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 153 shares acquired between March 3, 2016 and May 4, 2016 under the Mallinckrodt employee stock purchase plan.